Indeed, the antiproliferative activity of PPARγ is now investigated to limit and treat tumour cell proliferation although several PPARγ ligand-mediated antiproliferative effects act through a complexity of PPARγ-independent mechanisms [18]. Here, PPARG is linked to neoplasm.